2026-05-11T11:09:24-05:00 2025-12-31 263151447 HAN GROUP LLC 1020 19TH STREET NW SUITE 800 WASHINGTON DC 20036 990 2025-01-01 521609875 RESEARCHAMERICA RESE 7037392577 241 18TH STREET SOUTH 501 ARLINGTON VA 22202 MARY WOOLLEY PRESIDENT & CEO 7037392577 2026-05-11 1 JENNIFER S HAN P00633304 2022937000 2026-05-11 2025 2025-03-06 01:10:19Z MARY WOOLLEY 241 18TH STREET SOUTH 501 ARLINGTON VA 22202 10552456 0 X WWW.RESEARCHAMERICA.ORG X 1989 DC ADVOCATES FOR SCIENCE, DISCOVERY AND INNOVATION TO ACHIEVE BETTER HEALTH FOR ALL. 33 32 41 60 0 0 7414381 8575416 0 0 270061 314583 22362 24086 7706804 8914085 47759 49033 0 0 4725105 4682668 0 0 682097 2813379 4662483 7586243 9394184 120561 -480099 13036982 12060406 3522649 2465710 9514333 9594696 X 2025 WAS A TURBULENT YEAR FOR THE MEDICAL AND HEALTH RESEARCH COMMUNITY, BUT OUR COMMITMENT TO ADVOCATING FOR SCIENCE NEVER WAVERED. FROM PUSHING BACK AGAINST FUNDING THREATS TO ELEVATING RESEARCHERS' VOICES AND EQUIPPING ADVOCATES, WE KEPT SCIENCE VISIBLE. OUR WORK IS POSSIBLE BECAUSE OF OUR 300+ MEMBER ORGANIZATIONS AND THE COMMITTED INDIVIDUALS WHO ARE PART OF THESE ORGANIZATIONS. OUR VISION TO ACHIEVE THE FASTEST POSSIBLE PACE OF MEDICAL AND PUBLIC HEALTH PROGRESS IS ADVANCED BY OUR STEADFAST COMMITMENT TO OUR MISSION OF ADVOCACY FOR THE RESEARCH CONTINUUM. 0 0 2650426 ADVOCATING FOR SCIENCE, DISCOVERY, AND INNOVATION TO ACHIEVE BETTER HEALTH FOR ALL:THE RESEARCH!AMERICA ALLIANCE IS A DRIVING FORCE IN ADVOCATING WITH ONE VOICE TO REPRESENT THE R&D ECOSYSTEM. WE ADVOCATE FOR INCREASED FUNDING FOR OUR NATION'S MEDICAL, HEALTH AND SCIENTIFIC R&D FOCUSED FEDERAL AGENCIES. WE WORK WITH OUR MEMBERS AND INDIVIDUAL ADVOCATES TO ENCOURAGE CONGRESS AND THE ADMINISTRATION TO SUPPORT FAST-PACED MEDICAL PROGRESS AND ADVANCES IN PUBLIC HEALTH. OUR PACE IN 2025 WAS RELENTLESS: 54 CONGRESSIONAL MEETINGS, 36 ALLIANCE DISCUSSIONS, 31 NEW POLICY AND ADVOCACY RESOURCES, 11 LETTERS TO THE ADMINISTRATION, AND MUCH MORE. 2063700 AMERICANS FOR MEDICAL RESEARCH ADVOCACY CAMPAIGN:IN LIGHT OF UNPRECEDENTED CHALLENGES TO FEDERALLY-FUNDED MEDICAL RESEARCH IN 2025, RESEARCH!AMERICA, WITH SUPPORT FROM OVER 20 SCIENTIFIC SOCIETIES AND MANY FOUNDATIONS, LED A PUBLIC EDUCATION AND AWARENESS ADVERTISING CAMPAIGN: AMERICANS FOR MEDICAL RESEARCH. LAUNCHED IN SEPTEMBER, THE CAMPAIGN WAS ACTIVE IN WASHINGTON, D.C. AND IN FOUR STATES: KANSAS, NORTH CAROLINA, PENNSYLVANIA AND UTAH. THE CAMPAIGN GENERATED OVER 6 MILLION VIEWS OF ADS AND 340,000 VISITS TO THE WEBSITE. THE SCIENCE SOCIETY PARTNERS HELPED TO FIND DOZENS OF STORIES FROM PATIENTS, RESEARCHERS AND CLINICIANS IMPACTED BY CUTS TO NIH. SOME MADE THEIR WAY INTO OP-EDS, OTHERS DREW ATTENTION ON THE RESEARCH!AMERICA WEBSITE. 1348742 BOLSTERING OUR NATION'S R&D CAPACITY:THE SCIENCE AND TECHNOLOGY ACTION COMMITTEE (STAC) CONTINUED TO BRING TOGETHER NONPROFIT, ACADEMIC, FOUNDATION, AND CORPORATE LEADERS FOR THOUGHT LEADERSHIP TO DRAMATICALLY STRENGTHEN U.S. SCIENCE AND TECHNOLOGY. IN FEBRUARY 2025, STAC RELEASED THE VISION FOR AMERICAN SCIENCE AND TECHNOLOGY TO UNITE THE COMMUNITY IN MAKING THE CASE FOR A CLEAR VISION AND ACTIONABLE POLICY RECOMMENDATIONS FOR A SUPERCHARGED AMERICAN SCIENTIFIC ENTERPRISE. STAC ALSO WORKED CLOSELY WITH OTHER STAKEHOLDERS TO PUSH BACK AGAINST DRASTIC PROPOSED CUTS IN FY26 FUNDING FOR FEDERAL SCIENCE PROGRAMS. 670600 GLOBAL HEALTH R&D INITIATIVE:RESEARCH!AMERICA IS ADVANCING ADVOCACY TO PROTECT AND STRENGTHEN U.S. GOVERNMENT INVESTMENT IN GLOBAL HEALTH RESEARCH AND DEVELOPMENT (GH R&D) THROUGH NON-OFFICIAL DEVELOPMENT ASSISTANCE (NON-ODA) FUNDING. THE INITIATIVE DELIVERABLES FOCUS ON FUNDING FOR INFECTIOUS DISEASE R&D. PROTECTING TOPLINE FUNDING FOR NIH, MAKING THE CASE FOR THE SIGNIFICANCE OF NIH'S ROLE IN INFECTIOUS DISEASE RESEARCH AT THE NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID), AND WORKING TO PREVENT THE ELIMINATION OF THE FOGARTY INTERNATIONAL CENTER (FIC) ARE KEY OBJECTIVES OF THE INITIATIVE. 419966 ADVOCACY PROGRAMS:WE ANNUALLY HOST SEVERAL PARTNER PROGRAMS EACH YEAR, HIGHLIGHTING OUR CONVENING POWER AND ABILITY TO IDENTIFY AND FOCUS ATTENTION ON TIMELY RESEARCH AND DEVELOPMENT POLICY TOPICS. IN 2025, THE NATIONAL HEALTH RESEARCH FORUM PROVIDED PARTICIPANTS WITH THE OPPORTUNITY TO ENGAGE IN DIALOGUE THAT PROVIDED ACTIONABLE INSIGHTS AND FOSTERED COLLABORATIVE DISCUSSIONS INTO CRITICAL HEALTH AND SCIENTIFIC CHALLENGES FACING THE COUNTRY.IN 2025, WE WERE PLEASED TO INCREASE OUR FOCUS ON IN-PERSON CONGRESSIONAL BRIEFINGS. ONE OF THE PROGRAMS INCLUDED AN EXPERT PANEL ASSEMBLED TO DISCUSS THE SCIENCE BEHIND GENETICALLY TARGETED TECHNOLOGY AND THE EXTRAORDINARY CAPABILITY IT HOLDS TO ADDRESS URGENT UNMET MEDICAL NEEDS. OUR 2025 PROGRAMMING FEATURED EXPERT PANELISTS, REMARKS FROM CONGRESSIONAL CHAMPIONS, AS WELL AS NEW INFOGRAPHIC RESOURCES FOR CONGRESSIONAL STAFF AND ADVOCATES. WE LOOK FORWARD TO A CONTINUED EDUCATIONAL PRESENCE ON THE HILL IN 2026. 407494 49033 SCIENCE OUTREACH AND CIVIC ENGAGEMENT:EARLY CAREER SCIENTISTS ARE INCREASINGLY MOTIVATED TO ENGAGE WITH THEIR LOCAL COMMUNITIES. OUR CIVIC ENGAGEMENT MICROGRANT PROGRAM, NOW IN ITS 8TH YEAR, HAS BEEN PART OF THIS IMPORTANT TREND THANKS TO FOUNDATION SUPPORT. IN 2025, WE PROVIDED 24 MICROGRANTS TO EARLY CAREER STEMM GROUPS ACROSS THE COUNTRY. IN NOVEMBER, WE LAUNCHED THE 2025-2026 CYCLE AND RECEIVED A RECORD-SETTING 132 APPLICATIONS, A 22% INCREASE OVER LAST YEAR. WE ALSO COMPLETED A SUCCESSFUL FIRST YEAR OF A NEW CIVIC SCIENCE OPPORTUNITY - THE PUBLIC ENGAGEMENT CONTENT AWARDS, FOCUSED ON THE CREATION OF OPEN-ACCESS CURRICULA IN SKILLS NEEDED FOR EFFECTIVE PUBLIC ENGAGEMENT. WE PROVIDED 11 AWARDS OF UP TO $5,000 EACH AND RELEASED THE INNOVATIVE TRAINING CONTENT ON RESEARCH!AMERICA'S WEBSITE. 231083 OTHER PROGRAMS 1729143 49033 7792011 1 1 0 1 0 0 0 0 0 1 1 0 0 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 29 0 1 41 1 0 0 0 0 0 0 0 0 0 0 0 0 X 33 32 0 0 0 0 1 1 1 1 1 0 0 1 1 1 1 1 1 1 1 0 AL AK AR CA CO CT FL GA HI IL KS KY ME MD MA MI MN MS NV NH NJ NM NY NC ND OH OK OR PA RI SC TN VA WA WV WI X X MICHAEL COBURN 7037392577 241 18TH STREET SOUTH 501 ARLINGTON VA 22202 MARY WOOLLEY PRESIDENT & CHIEF EXECUTIVE OFFICER 50.00 X X 597619 0 55121 SUDIP PARIKH PHD CHAIR 3.00 X X 0 0 0 GEORGES BENJAMIN MD VICE CHAIR 2.00 X X 0 0 0 HAROLD L PAZ MD MS SECRETARY 2.00 X X 0 0 0 NANCY BROWN TREASURER 2.00 X X 0 0 0 KIRSTEN BIBBINS-DOMINGOPHD MD MAS DIRECTOR 1.00 X 0 0 0 DEBORAH DEAS MD MPH DIRECTOR 1.00 X 0 0 0 MIKAEL DOLSTEN MD PHD DIRECTOR (THRU APRIL) 1.00 X 0 0 0 VICTOR J DZAU MD DIRECTOR 1.00 X 0 0 0 KAFUI DZIRASA MD PHD DIRECTOR 1.00 X 0 0 0 AYMAN EL-MOHANDES MBBCH MD DIRECTOR 1.00 X 0 0 0 ARTHUR C EVANS JR PHD DIRECTOR 1.00 X 0 0 0 JULIE GERBERDING MD MPH DIRECTOR 1.00 X 0 0 0 HON BART GORDON DIRECTOR 1.00 X 0 0 0 CELINE GOUNDER MD SCM DIRECTOR 1.00 X 0 0 0 GARTH GRAHAM MD MPH DIRECTOR 1.00 X 0 0 0 MARY JC HENDRIX PHD DIRECTOR 1.00 X 0 0 0 HON RUSH D HOLT PHD DIRECTOR (THRU APRIL) 1.00 X 0 0 0 KAREN KNUDSEN PHD DIRECTOR (THRU SEPTEMBER) 1.00 X 0 0 0 LAURA MAGANA PHD DIRECTOR 1.00 X 0 0 0 MARK B MCCLELLAN MD PHD DIRECTOR 1.00 X 0 0 0 MICHELLE MCMURRY-HEATH MD PHD DIRECTOR 1.00 X 0 0 0 JESSICA L MEGA MD MPH DIRECTOR 1.00 X 0 0 0 MARY PITTMAN DRPH DIRECTOR (THRU APRIL) 1.00 X 0 0 0 CLAIRE POMEROY MD DIRECTOR 1.00 X 0 0 0 DEREK K RAPP DIRECTOR 1.00 X 0 0 0 E ALBERT REECE MD PHD MBA DIRECTOR 1.00 X 0 0 0 JOHN REED MD PHD DIRECTOR 1.00 X 0 0 0 DAVID REESE MD DIRECTOR 1.00 X 0 0 0 LEWIS G SANDY MD FACP DIRECTOR 1.00 X 0 0 0 HON DONNA SHALALA PHD DIRECTOR 1.00 X 0 0 0 SARAH L SZANTON PHD RN DIRECTOR 1.00 X 0 0 0 RAVI THADHANI MD MPH DIRECTOR 1.00 X 0 0 0 DEBORAH TRAUTMAN PHD RN FAAN DIRECTOR (THRU APRIL) 1.00 X 0 0 0 M ROY WILSON MD DIRECTOR 1.00 X 0 0 0 KEITH YAMAMOTO PHD DIRECTOR 1.00 X 0 0 0 CYNTHIA ZAGIEBOYLO DIRECTOR 1.00 X 0 0 0 ELIAS ZERHOUNI MD DIRECTOR 1.00 X 0 0 0 MICHAEL COBURN EXECUTIVE VICE PRESIDENT & COO 45.00 X 313758 0 39882 ELEANOR DEHONEY SR. VP OF POLICY & ADVOCACY 45.00 X 278226 0 37089 JENNIFER LURAY SR VP STRATEGY & PUBLIC ENGAGEMENT 45.00 X 246915 0 52491 SHEILA MURPHY VP - ADVOCACY PROGRAMS 45.00 X 225504 0 21394 ANNE MANDEVILLE VP DEVELOPMENT & MEMBERSHIP 45.00 X 214089 0 20515 GLENN O'NEAL SENIOR DIRECTOR - COMMUNICATIONS 45.00 X 150844 0 15300 2026955 0 241792 11 0 1 0 SKDKNICKERBOCKER LLC 285 FULTON ST 69TH FLOOR NEW YORK NY 10007 PUBLIC RELATIONS/ ADVOCACY CONSULTING 1679440 GLOBAL STRATEGY GROUP LLC 215 PARK AVE SOUTH 15TH FLOOR NEW YORK NY 10003 ADVOCACY/COMMUNICATIONS 587258 AXIOS MEDIA INC 3100 CLARENDON BOULEVARD SUITE 130 ARLINGTON VA 22201 EVENT PRODUCTION AND SUPPORT 250000 KOUNTOUPES DENHAM CARR & REID 607 14TH ST NW SUITE 750 WASHINGTON DC 20005 GOVERNMENT RELATIONS 240243 KEEFE SINGISER PARTNERS 4416 CHESAPEAKE ST NW WASHINGTON DC 20016 GOVERNMENT RELATIONS 220000 10 1352350 7223066 33574 8575416 181898 181898 45616 21530 24086 24086 24086 1749526 1616841 132685 132685 132685 8914085 0 0 338669 X 49033 49033 1006380 435189 357687 213504 2942496 2421924 226482 294090 204549 161914 20633 22002 268353 203955 35214 29184 260890 186798 42055 32037 20468 7490 12978 87900 87900 355092 355092 1823284 1801439 19714 2131 1416327 1349122 59741 7464 24342 19702 2536 2104 121363 98291 8508 14564 217694 178509 10885 28300 70266 62038 710 7518 351050 331635 17240 2175 199 199 76355 62611 3818 9926 18197 14921 910 2366 DUES AND SUBSCRIPTIONS 47974 44465 2420 1089 SURVEYS 23750 11419 11837 494 TAXES & LICENSES 8222 3954 4097 171 9394184 7792011 920076 682097 253589 820705 2897691 1594285 1590112 918407 244 638 48168 13062 703233 582802 178540 120431 6496473 7025610 1572165 1567268 13036982 12060406 730668 570863 949051 166881 1842930 1727966 3522649 2465710 X 688454 362531 8825879 9232165 9514333 9594696 13036982 12060406 -480099 560462 0 X X 0 1 X 1 0 X 7916222 3958577 4421376 7414381 8575416 32285972 7916222 3958577 4421376 7414381 8575416 32285972 12838676 19447296 73024 135771 243324 228427 227514 908060 631 23 10 664 33194696 8285712 0.58590 0.57230 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: MISCELLANEOUS - 2021 AMOUNT: $ 631. 2022 AMOUNT: $ 23. 2023 AMOUNT: $ 10. 2024 AMOUNT: $ 0. 2025 AMOUNT: $ 0. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 8099 346993 355092 9039092 9394184 619709 154927 0 0 459239 545668 529312 619709 2153928 3230892 328386 327738 286719 355092 1297935 114810 136417 132328 154927 538482 807723 9590 11071 9781 8099 38541 5293509 200000 683205 250000 5926714 4997988 200000 345521 250000 5293509 4404539 200000 643449 250000 4997988 5393479 200000 -988940 200000 4404539 100000 5100000 193479 5393479 1.00000 0 0 524438 446164 78274 99805 71921 27884 78990 64717 14273 120431 DEPOSITS 20888 DEFERRED COMPENSATION INVESTMENTS 1178551 RIGHT-OF-USE ASSETS - OPERATING LEASES 366054 PREPAID EVENT DEPOSITS 1775 1567268 DEFERRED COMPENSATION 1178551 OPERATING LEASE LIABILITY 526777 FINANCE LEASE LIABILITY 22638 1727966 X 9497633 560462 1556 21530 583548 8914085 0 8914085 9417270 1556 21530 23086 9394184 0 9394184 PART V, LINE 4: THE BOARD OF DIRECTORS HAS DESIGNATED AN AMOUNT OF $399,472 FOR A FUTURE USE TO BE DETERMINED AT A LATER TIME AND ONLY UPON APPROVAL OF THE BOARD. RESEARCH!AMERICA'S ENDOWMENT WAS ESTABLISHED IN FEBRUARY 2020 AND CONSISTS OF ONE FUND, ESTABLISHED TO SUPPORT THE GORDON AND LLURA GUND LEADERSHIP AWARD PRESENTED BY RESEARCH!AMERICA ANNUALLY AT ITS ADVOCACY AWARDS EVENT. IN 2021, JOHNSON & JOHNSON ESTABLISHED A PERMANENT ENDOWMENT TO PROVIDE SPONSORSHIP SUPPORT FOR THE PUBLIC HEALTH AWARDS AS PART OF THE ADVOCACY AWARDS EVENT. PART X, LINE 2: THE ORGANIZATION FOLLOWS THE AUTHORITATIVE GUIDANCE RELATING TO ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES INCLUDED IN ACCOUNTING STANDARDS CODIFICATION TOPIC 740-10, INCOME TAXES. THESE PROVISIONS PROVIDE CONSISTENT GUIDANCE FOR THE ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES RECOGNIZED IN AN ENTITY'S FINANCIAL STATEMENTS AND PRESCRIBE A THRESHOLD OF "MORE LIKELY THAN NOT" FOR RECOGNITION AND DERECOGNITION OF TAX POSITIONS TAKEN OR EXPECTED TO BE TAKEN IN A TAX RETURN. IT IS THE ORGANIZATION'S POLICY TO RECOGNIZE INTEREST AND/OR PENALTIES RELATED TO UNCERTAIN TAX POSITIONS, IF ANY, IN INCOME TAX EXPENSES. THE ORGANIZATION PERFORMED AN EVALUATION OF UNCERTAIN TAX POSITIONS FOR THE YEAR ENDED DECEMBER 31, 2025, AND DETERMINED THAT THERE WERE NO MATTERS THAT WOULD REQUIRE RECOGNITION ON THE FINANCIAL STATEMENTS OR THAT MAY HAVE ANY EFFECT ON ITS TAX-EXEMPT STATUS. THE STATUTE OF LIMITATIONS GENERALLY REMAINS OPEN FOR THREE TAX YEARS WITH THE U.S. FEDERAL JURISDICTION OR THE VARIOUS STATES AND LOCAL JURISDICTIONS IN WHICH THE ORGANIZATION FILES TAX RETURNS. PART XI, LINE 2D - OTHER ADJUSTMENTS: RENTAL EXPENSE 21,530. PART XII, LINE 2D - OTHER ADJUSTMENTS: RENTAL EXPENSE 21,530. X X X X X X 0 0 0 0 0 0 0 0 0 MARY WOOLLEY PRESIDENT & CHIEF EXECUTIVE OFFICER 574119 0 0 0 23500 0 28000 0 27121 0 652740 0 0 0 MICHAEL COBURN EXECUTIVE VICE PRESIDENT & COO 313758 0 0 0 0 0 25344 0 14538 0 353640 0 0 0 ELEANOR DEHONEY SR. VP OF POLICY & ADVOCACY 278226 0 0 0 0 0 22425 0 14664 0 315315 0 0 0 JENNIFER LURAY SR VP STRATEGY & PUBLIC ENGAGEMENT 246915 0 0 0 0 0 21164 0 31327 0 299406 0 0 0 SHEILA MURPHY VP - ADVOCACY PROGRAMS 225504 0 0 0 0 0 18114 0 3280 0 246898 0 0 0 ANNE MANDEVILLE VP DEVELOPMENT & MEMBERSHIP 214089 0 0 0 0 0 17250 0 3265 0 234604 0 0 0 GLENN O'NEAL SENIOR DIRECTOR - COMMUNICATIONS 150844 0 0 0 0 0 12025 0 3275 0 166144 0 0 0 X 4 31294 FMV X BEVERAGES 1 2280 FMV 0 1 0 PART I, COLUMN (B): THE TOTAL IN COLUMN (B) REPRESENTS THE TOTAL NUMBER OF CONTRIBUTION RECEIVED. FORM 990, PART VI, SECTION A, LINE 6 RESEARCH!AMERICA IS A MEMBERSHIP ORGANIZATION. MEMBERSHIP IS OPEN TO ANY ORGANIZATION, PROFESSIONAL SOCIETY, ASSOCIATION, CORPORATION, INSTITUTION, OTHER ENTITY OR INDIVIDUAL WHICH IS INTERESTED IN AND SUPPORTIVE OF THE MISSION OF RESEARCH!AMERICA - TO MAKE RESEARCH FOR HEALTH A HIGHER NATIONAL PRIORITY. MEMBERS ARE APPROVED BY THE BOARD OF DIRECTORS. FORM 990, PART VI, SECTION A, LINE 7A EACH INSTITUTION MEMBER HAS ONE VOTE ON MATTERS SUBJECT TO A VOTE BY THE MEMBERSHIP. MEMBERS ELECT THE BOARD OF DIRECTORS AT THE ANNUAL MEETING. FORM 990, PART VI, SECTION A, LINE 7B MEMBERS MAY BE ASKED TO VOTE ON MATTERS OUTLINED IN THE BYLAWS (ELECTION OF DIRECTORS AND DISSOLUTION OR AMENDMENTS TO THE BYLAWS). FORM 990, PART VI, SECTION B, LINE 11B THE DRAFT FORM 990 IS PRESENTED TO THE AUDIT COMMITTEE IN CONJUNCTION WITH THE PRESENTATION OF THE AUDIT REPORT FOR THE YEAR ENDED. ONCE APPROVED BY THE COMMITTEE, THE DRAFT FORM 990 IS DISTRIBUTED TO THE BOARD OF DIRECTORS, WHO ARE GIVEN A 48-HOUR PERIOD TO RESPOND WITH ANY ISSUES OR EDITS PRIOR TO FILING WITH THE INTERNAL REVENUE SERVICE. FORM 990, PART VI, SECTION B, LINE 12C THE AUDIT COMMITTEE IS CHARGED WITH OVERSIGHT OF ADHERENCE TO THE CONFLICT-OF-INTEREST POLICY. ANNUALLY, EACH MEMBER OF THE BOARD OF DIRECTORS AND EACH MEMBER OF STAFF IS REQUIRED TO REVIEW THE POLICY AND SUBMIT A SIGNED DISCLOSURE STATEMENT. THE AUDIT COMMITTEE REVIEWS AND REPORTS TO THE BOARD OF DIRECTORS ANY POTENTIAL CONFLICT OF INTEREST. ANY DIRECTOR WITH A DISCLOSED CONFLICT SHALL RECUSE THEMSELVES FROM DELIBERATIONS ON ACTIONS THAT MAY BE CONSTRUED AS A CONFLICT OF INTEREST. FORM 990, PART VI, SECTION B, LINE 15 THE COMPENSATION COMMITTEE IS CHARGED WITH OVERSIGHT OF EXECUTIVE COMPENSATION. THE COMPENSATION COMMITTEE, IN CONSULTATION WITH THE BOARD CHAIR, ESTABLISHES PERFORMANCE METRICS FOR THE CEO. FOLLOWING THE CLOSE OF THE YEAR, THE COMPENSATION COMMITTEE REVIEWS RESULTS TO DETERMINE THE OVERALL LEVEL OF PERFORMANCE. A THIRD-PARTY COMPENSATION CONSULTANT IS ENGAGED TO REVIEW MARKET COMPENSATION FOR THE PRESIDENT AND CEO AND KEY MANAGEMENT EMPLOYEES. THE COMPENSATION COMMITTEE MET MOST RECENTLY ON FEBRUARY 5, 2026, TO REVIEW COMPENSATION FOR THE CEO AND KEY EMPLOYEES FOR 2026. THE COMMITTEE MET ON FEBRUARY 6, 2025, TO REVIEW COMPENSATION FOR THE CEO AND KEY EMPLOYEES FOR 2025. THE COMMITTEE USES PERFORMANCE APPRAISALS AND DATA AND MARKET ANALYSIS FROM COMPENSATION CONSULTANTS TO GUIDE COMPENSATION DECISIONS. THE COMPENSATION COMMITTEE MAKES ITS RECOMMENDATION TO THE BOARD CHAIR AND PRESENTS THE REPORT TO THE BOARD OF DIRECTORS FOR CONSIDERATION AND APPROVAL. FORM 990, PART VI, SECTION C, LINE 19 CODE OF ETHICS, CONFLICT OF INTEREST AND WHISTLEBLOWER POLICY AND FINANCIAL INFORMATION IS AVAILABLE ON RESEARCH!AMERICA'S WEB SITE, THESE AND OTHER GOVERNING DOCUMENTS ARE ALSO AVAILABLE UPON REQUEST. FORM 990, PART IX, LINE 11G PROGRAM CONSULTING: PROGRAM SERVICE EXPENSES 1,575,282. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 1,575,282. CONSULTANT SERVICES: PROGRAM SERVICE EXPENSES 175,549. MANAGEMENT AND GENERAL EXPENSES 19,714. FUNDRAISING EXPENSES 2,131. TOTAL EXPENSES 197,394. HONORARIUM: PROGRAM SERVICE EXPENSES 50,608. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 50,608. FORM 990, PART XII, LINE 2C: THE PROCESS REMAINS UNCHANGED FROM THE PRIOR YEAR.